REO13 Melanoma With of Without GM-CSF

NCT03282188 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Withdrawn by Sponsor

Conditions

Melanoma
Cancer of Skin

Interventions

BIOLOGICAL: Reolysin
DRUG: GM-CSF

Sponsor

University of Leeds

Collaborators

[object Object]